These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


427 related items for PubMed ID: 16282513

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms.
    Wijnen PA, Op den Buijsch RA, Drent M, Kuijpers PM, Neef C, Bast A, Bekers O, Koek GH.
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():211-9. PubMed ID: 18081664
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J, Grundmann M.
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [Abstract] [Full Text] [Related]

  • 6. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF, Liu JP, Chowbay B.
    Drug Metab Rev; 2009 Jun; 41(2):89-295. PubMed ID: 19514967
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bioequivalence revisited: influence of age and sex on CYP enzymes.
    Bebia Z, Buch SC, Wilson JW, Frye RF, Romkes M, Cecchetti A, Chaves-Gnecco D, Branch RA.
    Clin Pharmacol Ther; 2004 Dec; 76(6):618-27. PubMed ID: 15592333
    [Abstract] [Full Text] [Related]

  • 14. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
    Sim SC, Kacevska M, Ingelman-Sundberg M.
    Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
    Arbus C, Benyamina A, Llorca PM, Baylé F, Bromet N, Massiere F, Garay RP, Hameg A.
    Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
    [Abstract] [Full Text] [Related]

  • 18. Gene-based drug prescribing: clinical implications of the cytochrome P450 genes.
    Musana AK, Wilke RA.
    WMJ; 2005 Aug; 104(6):61-6. PubMed ID: 16218319
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P, Kubiak-Tomaszewska G, Łukaszkiewicz J, Pachecka J.
    Acta Pol Pharm; 2008 Aug; 65(3):319-29. PubMed ID: 18646551
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.